Lazard, Inc. (NYSE:LAZ – Free Report) – Research analysts at Zacks Research raised their Q3 2025 earnings per share (EPS)…
Read More

Lazard, Inc. (NYSE:LAZ – Free Report) – Research analysts at Zacks Research raised their Q3 2025 earnings per share (EPS)…
Read More
RUTHERFORD, N.J. (AP) _ Vyant Bio, Inc. (VYNT) on Monday reported a loss of $7.4 million in its first quarter.…
Read More